
Sky high deal expectations at JPM 2024
The biotech industry is gearing up for JPM Week 2024 in San Francisco, with high expectations for mergers and acquisitions (M&A) following a successful end to 2023. Companies like Bristol Myers Squibb, Moderna, Novartis, and Sarepta Therapeutics are expected to make significant presentations. Updates from Vertex Pharmaceuticals and advancements in artificial intelligence (AI) are also…